Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa?
| dc.contributor.author | Jarvis, Joseph N | |
| dc.contributor.author | Harrison, Thomas S | |
| dc.contributor.author | Govender, Nelesh | |
| dc.contributor.author | Lawn, Stephen D | |
| dc.contributor.author | Longley, Nicky | |
| dc.contributor.author | Bicanic, Tihana | |
| dc.contributor.author | Maartens, Gary | |
| dc.contributor.author | Venter, Francois | |
| dc.contributor.author | Bekker, Linda-Gail | |
| dc.contributor.author | Wood, Robin | |
| dc.contributor.author | Meintjes, Graeme | |
| dc.date.accessioned | 2017-05-26T09:02:07Z | |
| dc.date.available | 2017-05-26T09:02:07Z | |
| dc.date.issued | 2011 | |
| dc.date.updated | 2016-01-08T10:17:36Z | |
| dc.description.abstract | Cryptococcal meningitis (CM) is a major cause of death among HIV-infected individuals. It causes an estimated 957 900 cases and 624 700 deaths worldwide annually, the vast majority of them in sub-Saharan Africa.1 In Cape Town, CM is now the most common cause of adult meningitis (63% of all microbiologically confirmed cases2), and acute outcomes are poor.3 Even with optimal treatment in study settings, 10-week mortality rates are between 24% and 37%.4,5 In 2009, in a routine care setting at an urban hospital in Johannesburg, 67% of patients had died or were lost to follow-up at 3 months (N Govender et al., unpublished data). Unfortunately almost half of South African patients still receive sub-optimal initial treatment with oral fluconazole rather than intravenous amphotericin B.3,6 Clearly, given the substantial mortality and morbidity associated with CM, preventive interventions should be prioritised. | |
| dc.identifier.apacitation | Jarvis, J. N., Harrison, T. S., Govender, N., Lawn, S. D., Longley, N., Bicanic, T., ... Meintjes, G. (2011). Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa?. <i>South African Medical Journal</i>, http://hdl.handle.net/11427/24418 | en_ZA |
| dc.identifier.chicagocitation | Jarvis, Joseph N, Thomas S Harrison, Nelesh Govender, Stephen D Lawn, Nicky Longley, Tihana Bicanic, Gary Maartens, et al "Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa?." <i>South African Medical Journal</i> (2011) http://hdl.handle.net/11427/24418 | en_ZA |
| dc.identifier.citation | Jarvis, J. N., Harrison, T. S., Govender, N., Lawn, S. D., Longley, N., Bicanic, T., ... & Meintjes, G. (2011). Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts: time to implement in South Africa?. SAMJ: South African Medical Journal, 101(4), 232-234. | |
| dc.identifier.ris | TY - Journal Article AU - Jarvis, Joseph N AU - Harrison, Thomas S AU - Govender, Nelesh AU - Lawn, Stephen D AU - Longley, Nicky AU - Bicanic, Tihana AU - Maartens, Gary AU - Venter, Francois AU - Bekker, Linda-Gail AU - Wood, Robin AU - Meintjes, Graeme AB - Cryptococcal meningitis (CM) is a major cause of death among HIV-infected individuals. It causes an estimated 957 900 cases and 624 700 deaths worldwide annually, the vast majority of them in sub-Saharan Africa.1 In Cape Town, CM is now the most common cause of adult meningitis (63% of all microbiologically confirmed cases2), and acute outcomes are poor.3 Even with optimal treatment in study settings, 10-week mortality rates are between 24% and 37%.4,5 In 2009, in a routine care setting at an urban hospital in Johannesburg, 67% of patients had died or were lost to follow-up at 3 months (N Govender et al., unpublished data). Unfortunately almost half of South African patients still receive sub-optimal initial treatment with oral fluconazole rather than intravenous amphotericin B.3,6 Clearly, given the substantial mortality and morbidity associated with CM, preventive interventions should be prioritised. DA - 2011 DB - OpenUCT DP - University of Cape Town J1 - South African Medical Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2011 T1 - Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa? TI - Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa? UR - http://hdl.handle.net/11427/24418 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/24418 | |
| dc.identifier.vancouvercitation | Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, et al. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa?. South African Medical Journal. 2011; http://hdl.handle.net/11427/24418. | en_ZA |
| dc.language.iso | eng | |
| dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | South African Medical Journal | |
| dc.source.uri | http://www.samj.org.za/index.php/samj | |
| dc.title | Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa? | |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |